- Filed
- May 6, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Mar 29, 2025 | 6.15M sh |
| Long Term Debt | Q1 2025 · Mar 29, 2025 | $37.55M |
| Long Term Debt | Q1 2025 · Dec 28, 2024 | $38.64M |
| Short Term Debt | Q1 2025 · Mar 29, 2025 | $3.98M |
| Short Term Debt | Q1 2025 · Dec 28, 2024 | $3.6M |
| Cash And Equivalents | Q1 2025 · Mar 29, 2025 | $7.9M |
| Cash And Equivalents | Q1 2025 · Dec 28, 2024 | $14.01M |
| Current Liabilities | Q1 2025 · Mar 29, 2025 | $39.58M |
| Current Liabilities | Q1 2025 · Dec 28, 2024 | $44.79M |
| Total Liabilities | Q1 2025 · Mar 29, 2025 | $111.33M |
| Total Liabilities | Q1 2025 · Dec 28, 2024 | $114.62M |
| Current Assets | Q1 2025 · Mar 29, 2025 | $109.62M |
| Current Assets | Q1 2025 · Dec 28, 2024 | $115.62M |
| Total Assets | Q1 2025 · Mar 29, 2025 | $232.33M |
| Total Assets | Q1 2025 · Dec 28, 2024 | $235.31M |
| Shares Diluted restated | Q1 2025 · Mar 30, 2024 | 6.26M sh |
| Stock Repurchased | Q1 2025 · Mar 30, 2024 | $234.8K |
| Capex restated | Q1 2025 · Mar 30, 2024 | $1.71M |
| Operating Cash Flow restated | Q1 2025 · Mar 30, 2024 | $2.78M |
| Eps Diluted | Q1 2025 · Mar 30, 2024 | $0.31 |
| Eps Basic | Q1 2025 · Mar 30, 2024 | $0.31 |
| Sga Expense restated | Q1 2025 · Mar 30, 2024 | $10.68M |
| Rd Expense | Q1 2025 · Mar 30, 2024 | $1.36M |
| Net Income | Q1 2025 · Mar 30, 2024 | $1.95M |
| Operating Income restated | Q1 2025 · Mar 30, 2024 | $3.41M |
| Gross Profit restated | Q1 2025 · Mar 30, 2024 | $15.45M |
| Cost Of Revenue restated | Q1 2025 · Mar 30, 2024 | $49.17M |